Dimensional Fund Advisors LP Supernus Pharmaceuticals, Inc. Call Options Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SUPN
# of Institutions
299Shares Held
60.9MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$411 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$243 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$201 Million2.64% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$104 Million0.09% of portfolio
-
State Street Corp Boston, MA2.16MShares$85.2 Million0.0% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.11B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...